“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism

Background: “Pill-in-the-pocket” (PIP) treatment with type IC drugs for cardioversion of recent-onset atrial fibrillation (AF) has been recommended in guidelines. Major adverse effects have been often reported, and the underlying mechanisms are proposed to be associated with the genetic backgrounds....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Linling Li, Yanfei Ruan, Nian Liu, Qianqian Zhao, Mengxia Zhang, Xin Li, Song Zuo, Jiang Le, Kui Wu, Rong Bai, Changsheng Ma
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2019-03-01
סדרה:Frontiers in Physiology
נושאים:
Brugada syndrome
atrial fibrillation
SCN5A
polymorphism
propafenone
גישה מקוונת:https://www.frontiersin.org/article/10.3389/fphys.2019.00353/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים